Send feedback

MTOR p.Lys202=

c.606A>G · rs975877678 · VCV1120283

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0117%, amr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.084GERP -2.9, phastCons 0.77
Overall
CADD7.076PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0117% Admixed American · 7/59,976 alleles
Filtering AF 0.00544% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00381%
Overall 0.00124% 20/1,613,956 alleles · ultra-rare exomes 13/1,461,862 · genomes 7/152,094 · joint denominator
Ancestry group Frequency 1 in
Admixed Americangrpmax 0.0117% 8,568
Remaining individualsnot grpmax-eligible 0.0032% 31,241
European (non-Finnish) 0.000932% 107,275

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MTOR
Protein
p.Lys202=
Coding
c.606A>G
MANE Select
NM_004958
dbSNP
rs975877678
Type
single nucleotide variant
Location
chr1:11256091 (GRCh38)
Gene constraint
LOEUF 0.268 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 78.57 · 73 PDB
Residue 202
the 'interaction with nbn' region
Full MTOR gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mtor-p-lys202 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown